17-20 November 2024 | Barcelona, Span
|
17-20 November 2024 | Barcelona, Span |
Maverex at ISPOR Europe 2024
A chance to connect
The Maverex team are excited to attend ISPOR Europe, the leading global conference for health economics and outcomes research (HEOR), where we’ll present our research, explore new methodologies, and learn more about the latest advancements in improving patient access to sustainable healthcare.
ISPOR Europe also provides an ideal setting for us to connect with clients and build strong relationships across the HEOR community. We look forward to discussing shared challenges and exploring collaborative opportunities.
We share six posters from our attendance at ISPOR Europe ‘24, covering topics from HTA landscaping to reducing the carbon footprint in healthcare, and much more.
More from Maverex
A comprehensive review of NICE Highly Specialised Technology appraisals (A)
Adherence to NICE guidelines for COPD can improve patient outcomes and reduce carbon footprint (B)
Introduction of faecal calprotectin testing into the UK IBD diagnostic pathway reduces environmental burden (C)
Identification of clinical effectiveness evidence in UK NICE single technology appraisal company submissions (D)
Disparities in new drug recommendations: A comparative analysis between NICE and the SMC (E)
A review of HTAs conducted for tumour-agnostic therapies across the UK and EU4 (F)
Download our event posters
Get to know Maverex
.
Find out more about our market access and HEOR services.
-
Connect
Members of the Maverex Team are on hand to help answer your questions and queries at the stand. They’re just some of our dedicated team, why not meet the rest?
-
Discover
Our specialised cross-functional teams work across all market access needs. From Evidence Generation to Economic and Environmental Modelling, explore our full range of services.
-
Explore
Our customers value the services and high-quality deliverables we provide, and they continue to work with us again and again. Explore some of our recent publications.
Keep the conversation going
There’s much more to Maverex
Maverex is global market access consultancy with over 30 highly-skilled professionals specialising in health economics, statistics, epidemiology, and market access, and a shared commitment to environmental responsibility. Our team thrives on collaboration, fostering a culture of innovation, support, and problem-solving through continuous learning and the sharing of expertise. Known for our scientific rigor, responsiveness, and high-quality deliverables, our customers value the services we provide, and they continue to work with us again and again.
Recent feedback
